CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-01 | Walker Neal CEO | Option exercise · Restricted Stock Units | −9,467 | 9,467 | ||
| 2025-03-01 | Walker Neal CEO | Option exercise | +9,466 | 1,470,184 | ||
| 2025-03-01 | Walker Neal CEO | Shares withheld for taxes | −3,277 | $1.99 | $7K | 1,466,907 |
| 2025-03-01 | Walker Neal CEO | Option exercise · Restricted Stock Units | −9,466 | 18,934 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +50,000 | 281,995 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +10,925 | 292,920 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −27,258 | $1.99 | $54K | 265,662 |
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −50,000 | 0 | ||
| 2025-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −10,925 | 10,925 | ||
| 2025-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,100 | 90,960 | ||
| 2025-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +2,375 | 93,335 | ||
| 2025-03-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −727 | $1.99 | $1K | 92,608 |
| 2025-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,100 | 0 | ||
| 2025-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −2,375 | 2,375 | ||
| 2025-02-03 | Davis Hugh M. President and COO | Grant or award · Restricted Stock Units | +74,700 | 74,700 | ||
| 2025-02-03 | Davis Hugh M. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +261,600 | 261,600 | ||
| 2025-02-03 | Walker Neal INTERIM CEO | Grant or award · Restricted Stock Units | +253,900 | 253,900 | ||
| 2025-02-03 | Walker Neal INTERIM CEO | Grant or award · Employee Stock Option (Right to Buy) | +888,800 | 888,800 | ||
| 2025-02-03 | Monahan Joseph Chief Scientific Officer | Grant or award · Restricted Stock Units | +83,900 | 83,900 | ||
| 2025-02-03 | Monahan Joseph Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +293,500 | 293,500 |
Page 7 of 34 · 680 trades